Cargando…

The efficacy and safety of (125)I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer

OBJECTIVE: To evaluate the safety and effectiveness of Iodine-125 ( (125)I) brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer. METHODS: In this study, a total of thirty-seven individuals suffering from locally advanced he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Menglong, Zhang, Jian, Hu, Bijuan, Huang, Liyin, Song, Shanjun, Zhu, Haitao, Chen, Chao, Chu, Cunkun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515616/ https://www.ncbi.nlm.nih.gov/pubmed/36185214 http://dx.doi.org/10.3389/fonc.2022.992399

Ejemplares similares

CT-MR Image Fusion for Post-Implant Dosimetry Analysis in Brain Tumor Seed Implantation- a Preliminary Study
por: Zhang, Menglong, et al.
Publicado: (2022)

CalliSpheres(®) microsphere transarterial chemoembolization combined with (125)I brachytherapy for patients with non–small‐cell lung cancer liver metastases
por: Zhao, Guangsheng, et al.
Publicado: (2022)

Efficacy Investigation of TACE Combined with Lenvatinib and Sintilimab in Intermediate-Stage Hepatocellular Carcinoma
por: Zhang, Menglong, et al.
Publicado: (2022)

miR-302a-3p Promotes Radiotherapy Sensitivity of Hepatocellular Carcinoma by Regulating Cell Cycle via MCL1
por: Yang, Zifeng, et al.
Publicado: (2022)

Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs. (125)Iodine Implantation
por: Hu, Hong-Tao, et al.
Publicado: (2021)

Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Jun-Ning, et al.
Publicado: (2023)

Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres(®) Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
por: Liang, Bin, et al.
Publicado: (2021)

Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis
por: Liu, Jun-Ning, et al.
Publicado: (2023)

The Efficacy and Safety of Transarterial Chemoembolization Plus Iodine 125 Seed Implantation in the Treatment of Hepatocellular Carcinoma With Oligometastases: A Case Series Reports
por: Zhang, Weihua, et al.
Publicado: (2022)

Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems
por: Müller, Lukas, et al.
Publicado: (2022)

CT-Guided (125)I Brachytherapy in the Treatment of Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization: A Pilot Study
por: Xu, Xinjian, et al.
Publicado: (2021)

Efficacy and safety of transarterial chemoembolization with CalliSpheres® Microspheres in head and neck cancer
por: Gao, Fei, et al.
Publicado: (2022)

Transarterial chemoembolization of liver metastasis from renal cell carcinoma
por: Matsuda, Hiroto, et al.
Publicado: (2018)

Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres(®) Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma
por: Duan, Xuhua, et al.
Publicado: (2022)

Clinical application and accuracy assessment of imaging-based surgical navigation guided (125)I interstitial brachytherapy in deep head and neck regions
por: Zhang, Guohao, et al.
Publicado: (2022)

Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study
por: Guo, Yongjian, et al.
Publicado: (2023)

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
por: Zhou, Qunfang, et al.
Publicado: (2020)

Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
por: Chen, Lei, et al.
Publicado: (2020)

Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices
por: Tao, Ziwen, et al.
Publicado: (2021)

Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
por: Huang, Jingjun, et al.
Publicado: (2022)

Gut microbiota changes and biological mechanism in hepatocellular carcinoma after transarterial chemoembolization treatment
por: Bian, Chao-fan, et al.
Publicado: (2022)

Prediction of bile duct injury after transarterial chemoembolization for hepatocellular carcinoma: Model establishment and verification
por: Guo, Jianxi, et al.
Publicado: (2022)

Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas' Responses to Transarterial Chemoembolization
por: Moawad, Ahmed W., et al.
Publicado: (2020)

Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Jin, Zhi-Cheng, et al.
Publicado: (2021)

Dosimetric Evaluation and Clinical Application of Radioactive Iodine-125 Brachytherapy Stent in the Treatment of Malignant Esophageal Obstruction
por: Ji, Zhe, et al.
Publicado: (2022)

The impact of liver abscess formation on prognosis of patients with malignant liver tumors after transarterial chemoembolization
por: Wang, Yunan, et al.
Publicado: (2023)

Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using (18)F-Fluorothymidine PET
por: Sharma, Rohini, et al.
Publicado: (2020)

Longitudinal Analysis of the Effect of Repeated Transarterial Chemoembolization for Liver Cancer on Portal Venous Pressure
por: Frangakis, Constantine, et al.
Publicado: (2021)

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
por: Zhang, Xia, et al.
Publicado: (2023)

I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma
por: Gao, Fu-Lei, et al.
Publicado: (2022)

Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer
por: Breen, William, et al.
Publicado: (2018)

Safety and Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma
por: Yang, Fei, et al.
Publicado: (2022)

Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma
por: Xia, Wei-Li, et al.
Publicado: (2022)

Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Zhao, Ying, et al.
Publicado: (2021)

Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning
por: Peng, Jie, et al.
Publicado: (2021)

Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib
por: Zhang, Lei, et al.
Publicado: (2020)

Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy
por: Zhang, Yue-Lin, et al.
Publicado: (2020)

Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kan, Xuefeng, et al.
Publicado: (2020)

Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
por: Lu, Linbin, et al.
Publicado: (2021)

Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment
por: Pelizzaro, Filippo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_odu3t3g7bhcfa218ta7tb8enun